Association between accelerometer-measured amplitude of rest-activity rhythm and future health risk: a prospective cohort study of the UK Biobank
- PMID: 37148892
- DOI: 10.1016/S2666-7568(23)00056-9
Association between accelerometer-measured amplitude of rest-activity rhythm and future health risk: a prospective cohort study of the UK Biobank
Abstract
Background: The health effects of rest-activity rhythm are of major interest to public health, but its associations with health outcomes remain elusive. We aimed to examine the associations between accelerometer-measured rest-activity rhythm amplitude and health risks among the general UK population.
Methods: We did a prospective cohort analysis of UK Biobank participants aged 43-79 years with valid wrist-worn accelerometer data. Low rest-activity rhythm amplitude was defined as the first quintile of relative amplitude; all other quintiles were classified as high rest-activity rhythm amplitude. Outcomes of interest were defined using International Classification of Diseases 10th Revision codes and consisted of incident cancer and cardiovascular, infectious, respiratory, and digestive diseases, and all-cause and disease-specific (cardiovascular, cancer, and respiratory) mortality. Participants with a current diagnosis of any outcome of interest were excluded. We assessed the associations between decreased rest-activity rhythm amplitude and outcomes using Cox proportional hazards models.
Findings: Between June 1, 2013, and Dec 23, 2015, 103 682 participants with available raw accelerometer data were enrolled. 92 614 participants (52 219 [56·4%] women and 40 395 [42·6%] men) with a median age of 64 years (IQR 56-69) were recruited. Median follow-up was 6·4 years (IQR 5·8-6·9). Decreased rest-activity rhythm amplitude was significantly associated with increased incidence of cardiovascular diseases (adjusted hazard ratio 1·11 [95% CI 1·05-1·16]), cancer (1·08 [1·01-1·16]), infectious diseases (1·31 [1·22-1·41]), respiratory diseases (1·26 [1·19-1·34]), and digestive diseases (1·08 [1·03-1·14]), as well as all-cause mortality (1·54 [1·40-1·70]) and disease-specific mortality (1·73 [1·34-2·22] for cardiovascular diseases, 1·32 [1·13-1·55] for cancer, and 1·62 [1·25-2·09] for respiratory diseases). Most of these associations were not modified by age older than 65 years or sex. Among 16 accelerometer-measured rest-activity parameters, low rest-activity rhythm amplitude had the strongest or second- strongest associations with nine health outcomes.
Interpretation: Our results suggest that low rest-activity rhythm amplitude might contribute to major health outcomes and provide further evidence to promote risk-modifying strategies associated with rest-activity rhythm to improve health and longevity.
Funding: National Natural Science Foundation of China and China Postdoctoral Science Foundation.
Copyright © 2023 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license. Published by Elsevier Ltd.. All rights reserved.
Conflict of interest statement
Declaration of interests YKW reports grants from the Hong Kong Research Grant Council General Research Fund and Collaborative Research Fund; consultation fees from Eisai; and honoraria from Eisai Hong Kong, outside the submitted work. CB was part of the scientific advisory board for Repha between 2020 and 2021, unrelated to the submitted work. All other authors declare no competing interests.
Comment in
-
Rest-activity rhythm as a clinical biomarker: what are the next steps?Lancet Healthy Longev. 2023 May;4(5):e179-e180. doi: 10.1016/S2666-7568(23)00065-X. Lancet Healthy Longev. 2023. PMID: 37148887 Free PMC article. No abstract available.
-
Rest-activity rhythm as a clinical biomarker in cancer.Lancet Healthy Longev. 2023 Jul;4(7):e304. doi: 10.1016/S2666-7568(23)00108-3. Lancet Healthy Longev. 2023. PMID: 37421957 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials